Preview: Pfizer's India Unit Edges Up Ahead Of Sept: qtr results

Pfizer

11/11/2022 08:45

** Shares of Pfizer Ltd  PFIZ.NS  rise as much as 0.7% to
4,388.9 rupees, ahead of its Sept-qtr results on Friday
    ** PFIZ's revenue is expected to decline in the mid-single
digit percentage range y-o-y as sales of COVID-19-related
products ease from peaks, research analysts at Nirmal Bang
Equities said
    ** Co serves India, Bangladesh, Sri Lanka and Nepal markets
    ** The pharmaceutical company with a portfolio of about 150
products reported a net profit of 1.43 billion rupees ($17.71
million) for the same period last year
    ** Five of the 6 analysts covering the stock have a "buy" or
"strong buy" rating, while 1 rate it "hold;" median PT is
5,298.5 rupees - Refinitiv data
    ** Stock down 13.2% so far this year, as of last close vs
Nifty Pharma Index's  .NIPHARM  8.7% fall
    ($1 = 80.7580 Indian rupees)
 (Reporting by Priya Sagar in Bengaluru)
 ((Priya.Sagar@thomsonreuters.com;))